Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer
Clinical trial NCT02879994 · COMPLETED
Trial details
- NCT number
- NCT02879994
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-15
- Primary completion
- 2017-11-30
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.